Lokelma (sodium zirconium cyclosilicate) for the Treatment of Adults with Hyperkalaemia
Lokelma is an oral suspension of sodium zirconium cyclosilicate that is indicated for the treatment of patients with hyperkalaemia.
GMP Custom API and Dosage Form Services for Clinical Needs
Hauptstrasse 62,
CH,
Binningen,
4102 Other,
Switzerland
Custom pharmaceutical services (CPS) draws on the company’s expertise in pharmaceutical development and manufacturing to provide custom manufacturing and development services for regulated starting materials (RSM), intermediates, drug substance (API) and drug product (dosage form) needs with an exceptionally wide range of capabilities.
CPS caters to the needs of innovators with a wide range of service offerings which include niche services like high potent drugs, steroids, solutions to complex chiral molecules, activated mPEG’s, life cycle management (LCM) options, combination dosage form products etc.
Process R&D – analytical R&D and scale-up
Infrastructure
Infrastructure
High potent GMP API contract manufacturing
Steroidal API contract manufacturing
Infrastructure
Formulation development
Infrastructure
Contract GMP manufacturing
Infrastructure
CPS has assembled an industry-leading portfolio of technologies with specific strengths in chiral chemistry. Our main focus is on catalysis as this provides long-term advantages and sustainability for chemical processing. Technologies include: asymmetric hydrogenation, hydro-formylation and biocatalysis – working together with customers we have proven ability to select and combine technologies to deliver optimal solutions to even the most challenging of projects.
Over the last five years, CPS has manufactured and supplied activated mPEGs for the conjugation of proteins, antibody fragments and peptides; to improve the stability and the pharmaco-kinetic properties of biologic drugs. With outstanding GMP capabilities and back integration to high purity mPEG-OH, we can guarantee the quality and security of supply of our activated mPEG products.
Lokelma is an oral suspension of sodium zirconium cyclosilicate that is indicated for the treatment of patients with hyperkalaemia.
Hauptstrasse 62
CH
Binningen
4102
Other
Switzerland